NYSEARCA:XPHSPDR S&P Pharmaceuticals ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $43.17 +0.02 (+0.05 %) (As of 07/6/2020 04:00 PM ET) Add Share Today's Range$43.04Now: $43.17▼$43.6850-Day Range$40.87MA: $42.90▼$44.1852-Week Range$30.30Now: $43.17▼$48.12Volume39,600 shsAverage Volume121,857 shsMarket Capitalization$243.91 millionP/E RatioN/ADividend Yield0.68%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Read More Geographic Exposure of XPHCurrency Exposure of XPHSector Exposure of XPHIndustry Exposure of XPH Basic Details Issuer SSgA Fund NameSPDR S&P Pharmaceuticals ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:XPH Inception Date6/19/2006 Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson Webwww.spdrs.com Phone+1-617-6644738 Fund Focus Asset ClassEquity BenchmarkS&P Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$243.73 million Average Daily Volume$121,103.50 Discount/Premium0.03% ETF Expenses Management Fee0.35% Other Expenses0.00% Total Expenses0.35% Fee Waiver0.00% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorSSGA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerCredit Suisse AMEX:XPH Rates by TradingView Receive XPH News and Ratings via Email Sign-up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Frequently Asked Questions How has SPDR S&P Pharmaceuticals ETF's stock been impacted by COVID-19 (Coronavirus)? SPDR S&P Pharmaceuticals ETF's stock was trading at $37.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XPH stock has increased by 15.4% and is now trading at $43.17. View which stocks have been most impacted by Coronavirus. How often does SPDR S&P Pharmaceuticals ETF pay dividends? What is the dividend yield for SPDR S&P Pharmaceuticals ETF? SPDR S&P Pharmaceuticals ETF declared a quarterly dividend on Monday, December 23rd. Shareholders of record on Tuesday, December 24th will be paid a dividend of $0.0711 per share on Friday, December 27th. This represents a $0.28 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Monday, December 23rd. This is a positive change from SPDR S&P Pharmaceuticals ETF's previous quarterly dividend of $0.07. View SPDR S&P Pharmaceuticals ETF's dividend history. Has SPDR S&P Pharmaceuticals ETF been receiving favorable news coverage? Media headlines about XPH stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. SPDR S&P Pharmaceuticals ETF earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about SPDR S&P Pharmaceuticals ETF. What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Target (TGT), Broadcom (AVGO), ConocoPhillips (COP), Chevron (CVX), Docusign (DOCU), SPDR Gold Shares (GLD), JPMorgan Chase & Co. (JPM) and Micron Technology (MU). Who are SPDR S&P Pharmaceuticals ETF's key executives? SPDR S&P Pharmaceuticals ETF's management team includes the following people: James E. Ross, President, Trustee (Age 52)Peter A. Ambrosini, Chief Compliance Officer (Age 69)Michael P. Riley, Vice President (Age 44)Gary L. French, Treasurer (Age 64)John W. Clark, Assistant Treasurer (Age 46)Matthew W. Flaherty, Assistant Treasurer (Age 42)Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)Mary Moran Zeven, Secretary (Age 52)Scott M. Zoltowski, Assistant Secretary (Age 44)Dave Kelly, Independent Trustee What is SPDR S&P Pharmaceuticals ETF's stock symbol? SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH." How do I buy shares of SPDR S&P Pharmaceuticals ETF? Shares of XPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is SPDR S&P Pharmaceuticals ETF's stock price today? One share of XPH stock can currently be purchased for approximately $43.17. How big of a company is SPDR S&P Pharmaceuticals ETF? SPDR S&P Pharmaceuticals ETF has a market capitalization of $243.91 million. What is SPDR S&P Pharmaceuticals ETF's official website? The official website for SPDR S&P Pharmaceuticals ETF is www.spdrs.com. How can I contact SPDR S&P Pharmaceuticals ETF? SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The company can be reached via phone at +1-617-6644738. This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
